Patients with NPM1 mutated AML commonly have co-mutated DNMT3A and/or FLT3-ITD and are associated with a characteristic gene expression profile including downregulation of CD34 and overexpression of HOXA cluster genes [46]. The gene discussed is FLT3; the disease is acute myeloid leukemia.